Literature DB >> 30416576

Curcumin Analogue GO-Y030 Significantly Improves Pressure Overload-induced Heart Failure in Vivo.

Kana Shimizu1, Masafumi Funamoto1, Mai Genpei1, Yoichi Sunagawa1, Yasufumi Katanasaka1, Yusuke Miyazaki1, Hiroyuki Shibata2, Hiromichi Wada3, Koji Hasegawa3, Tatsuya Morimoto3.   

Abstract

Entities:  

Keywords:  Acetylation; Analogue; Curcumin; Heart failure; p300

Year:  2017        PMID: 30416576      PMCID: PMC6213181          DOI: 10.15420/ecr.2017:23:15

Source DB:  PubMed          Journal:  Eur Cardiol        ISSN: 1758-3756


× No keyword cloud information.
  4 in total

1.  Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer.

Authors:  Hisatsugu Ohori; Hiroyuki Yamakoshi; Masaki Tomizawa; Masatoshi Shibuya; Yuichi Kakudo; Atsuko Takahashi; Shin Takahashi; Satoshi Kato; Takao Suzuki; Chikashi Ishioka; Yoshiharu Iwabuchi; Hiroyuki Shibata
Journal:  Mol Cancer Ther       Date:  2006-10       Impact factor: 6.261

Review 2.  Bioavailability of curcumin: problems and promises.

Authors:  Preetha Anand; Ajaikumar B Kunnumakkara; Robert A Newman; Bharat B Aggarwal
Journal:  Mol Pharm       Date:  2007-11-14       Impact factor: 4.939

3.  The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats.

Authors:  Tatsuya Morimoto; Yoichi Sunagawa; Teruhisa Kawamura; Tomohide Takaya; Hiromichi Wada; Atsushi Nagasawa; Masashi Komeda; Masatoshi Fujita; Akira Shimatsu; Toru Kita; Koji Hasegawa
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

4.  Cardiac p300 is involved in myocyte growth with decompensated heart failure.

Authors:  Tetsuhiko Yanazume; Koji Hasegawa; Tatsuya Morimoto; Teruhisa Kawamura; Hiromichi Wada; Akira Matsumori; Yosuke Kawase; Maretoshi Hirai; Toru Kita
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

  4 in total
  1 in total

1.  The Curcumin Analog GO-Y030 Controls the Generation and Stability of Regulatory T Cells.

Authors:  Takashi MaruYama; Shuhei Kobayashi; Hiroko Nakatsukasa; Yuki Moritoki; Daiki Taguchi; Yoichi Sunagawa; Tatsuya Morimoto; Atsuko Asao; Wenwen Jin; Yuji Owada; Naoto Ishii; Yoshiharu Iwabuchi; Akihiko Yoshimura; WanJun Chen; Hiroyuki Shibata
Journal:  Front Immunol       Date:  2021-06-23       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.